Copyright © 2015 Anna C. Roberts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Type 2 diabetes (T2DM) confers increased risk of endothelial dysfunction, coronary heart disease, and vulnerability to vein graft failure after bypass grafting, despite glycaemic control. This study explored the concept that endothelial cells (EC) cultured from T2DMand nondiabetic (ND) patients are phenotypically and functionally distinct. Cultured human saphenous vein- (SV-) ECwere compared between T2DM and ND patients in parallel. Proliferation, migration, and in vitro angiogenesis assays...
Copyright © 2015 Poojitha Rajasekar et al. This is an open access article distributed under the Crea...
Background: The potential clinical application of bone marrow or peripheral blood-derived progenitor...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Type 2 diabetes (T2DM) confers increased risk of endothelial dysfunction, coronary heart disease, an...
yesType 2 diabetes (T2DM) confers increased risk of endothelial dysfunction, coronary heart disease,...
Background Diabetic patients exhibit an increased risk of saphenous graft occlusion after coronary b...
Copyright © 2015 V. Altabas. This is an open access article distributed under the Creative Commons A...
Introduction: Diabetes Mellitus (DM) has been known to be a risk factor for the development of more ...
The disease burden of diabetes mellitus (DM) and its associated cardiovascular complications represe...
Cardiovascular complications have been major concerns in the treatment of diabetes, and up to 80% of...
Background. High blood and tissue concentrations of glu-cose and advanced glycation end-products (AG...
Coronary heart disease is the leading cause of morbidity in patients with type 2 diabetes mellitus (...
AIMS: Vascular endothelial cells play a major role in maintaining cardiovascular homeostasis in he...
Objective: Diabetes associated endothelial dysfunction, which determines both long and short term gr...
Diabetes induced hyperglycemia increases the risk of cardiovascular complications as it impacts vasc...
Copyright © 2015 Poojitha Rajasekar et al. This is an open access article distributed under the Crea...
Background: The potential clinical application of bone marrow or peripheral blood-derived progenitor...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...
Type 2 diabetes (T2DM) confers increased risk of endothelial dysfunction, coronary heart disease, an...
yesType 2 diabetes (T2DM) confers increased risk of endothelial dysfunction, coronary heart disease,...
Background Diabetic patients exhibit an increased risk of saphenous graft occlusion after coronary b...
Copyright © 2015 V. Altabas. This is an open access article distributed under the Creative Commons A...
Introduction: Diabetes Mellitus (DM) has been known to be a risk factor for the development of more ...
The disease burden of diabetes mellitus (DM) and its associated cardiovascular complications represe...
Cardiovascular complications have been major concerns in the treatment of diabetes, and up to 80% of...
Background. High blood and tissue concentrations of glu-cose and advanced glycation end-products (AG...
Coronary heart disease is the leading cause of morbidity in patients with type 2 diabetes mellitus (...
AIMS: Vascular endothelial cells play a major role in maintaining cardiovascular homeostasis in he...
Objective: Diabetes associated endothelial dysfunction, which determines both long and short term gr...
Diabetes induced hyperglycemia increases the risk of cardiovascular complications as it impacts vasc...
Copyright © 2015 Poojitha Rajasekar et al. This is an open access article distributed under the Crea...
Background: The potential clinical application of bone marrow or peripheral blood-derived progenitor...
Many preclinical evaluations of autologous small-diameter tissue-engineered vascular grafts (TEVGs) ...